CharMark: A Markov Approach to Linguistic Biomarkers in Dementia

Kevin Mekulu1, Faisal Aqlan2, Hui Yang1

  • 1Complex Systems Monitoring, Modeling and Control Laboratory, Pennsylvania State University, University Park, PA 16802, USA.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
668